PLANNING TOOLS & RESOURCES

CDC Planning Checklists

Healthcare Planning
Business Planning
State and Local Planning

Healthcare Planning

Home Healthcare Services Checklist This checklist identifies specific steps that home healthcare service providers can take now to prepare for a pandemic. Download this PDF English - 204KB

Medical Offices and Clinics Checklist Specific steps are outlined in this checklist that medical offices and clinics, including outpatient care clinics, can take to prepare for a pandemic. Download this PDF English - 176KB

Emergency Medical Service and Medical Transport Checklist EMS and medical transport organizations can use this checklist to help prepare for a pandemic. Download this PDF English - 228KB

Hospital Preparedness Checklist for state and local hospitals to help prepare for a pandemic Download this PDF English - 40KB

Long-Term Care and Other Residential Facilities Pandemic Influenza Planning Checklist The checklist identifies key areas: a structure for planning and decision making, and a written plan with subplans. Download this PDF English - 140KB

Business Planning

Business Pandemic Influenza Planning Checklist Download this PDF English - 288KB

State and Local Planning

State and Local Pandemic Influenza Planning Checklist Download this PDF English - 124KB

 
Important Safety Information About RELENZA

• Serious cases of bronchospasm, including fatalities, have been reported during treatment with RELENZA in patients with and without underlying airway disease. Many of these cases were reported during postmarketing, and causality was difficult to assess
  
• RELENZA SHOULD BE DISCONTINUED IN ANY PATIENT WHO DEVELOPS BRONCHOSPASM OR DECLINE IN RESPIRATORY FUNCTION; immediate treatment and hospitalization may be required
  
• Safety and efficacy have not been demonstrated in patients with high-risk underlying medical conditions
  
• Patients should be instructed in the use of the delivery system. Instructions should include a demonstration whenever possible
  
• If treatment with RELENZA is considered for a patient with underlying airway disease, the potential risks and benefits should be carefully weighed. If a decision is made to prescribe RELENZA for such a patient, this should be done only under conditions of careful monitoring of respiratory function, close observation, and appropriate supportive care including availability of fast-acting bronchodilators
  
• Common adverse events in treatment and prophylaxis studies with RELENZA were nausea, diarrhea, sinusitis, viral respiratory infections, headaches, nasal signs and symptoms. The incidence of these adverse events was similar in both groups for RELENZA and placebo-treated groups
  
• Please see complete Prescribing Information for RELENZA